GlobeNewswire Inc | Sep 8, 2020 08:30AM EDT

September 08, 2020

NEWPORT BEACH, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming virtual investor conferences.

Event: Wells Fargo 2020 Virtual Healthcare ConferenceFormat: Virtual Fireside chatDate: Thursday, September 10, 2020Time: 1:20 ? 1:50pm ET Event: H.C. Wainwright 22^nd Annual Global Investment ConferenceFormat: Virtual Fireside chatDate: Tuesday, September 15, 2020Time: 12:30 ? 12:50pm ET Event: Cantor 2020 Virtual Global Healthcare ConferenceFormat: Virtual Fireside chatDate: Thursday, September 17, 2020Time: 11:20 ? 11:50am ET

An audio webcast of Evolus presentation will be available on the investor relations section of Evolus website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolusis a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, theU.S. Food and Drug Administrationapproved Jeuveau (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveau is powered byEvolus'unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at:www.evolus.com.

Jeuveau is a registered trademark of Evolus, Inc.

Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:Ashwin Agarwal, Evolus, Inc.Vice President, Finance, Investor Relations & TreasuryTel: +1-949-284-4559Email: IR@Evolus.com

Media Contact:Crystal Muilenburg, Evolus, Inc.Vice President, Corporate Communications & Public RelationsTel: +1-949-284-4506Email: media@evolus.com